Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2021-06-10
2022-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Neurodevelopment in Adolescents With Congenital Heart Disease
NCT02759263
Improving Neurodevelopmental Outcomes in Children With Congenital Heart Disease: An Intervention Study
NCT03023644
Cogmed for Working Memory After TBI
NCT02305212
Cognitive Intervention to Improve Memory in Heart Failure Patients
NCT03035565
Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure
NCT05601817
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In summary, SVHD adolescents have significant cognitive deficits that are linked to brain injury in regions, which control such functions. Intervention to improve cognition and brain injury in SVHD is unclear, but a potential innovative treatment for such symptoms and brain injury is Cogmed®. The information from this pilot study has the potential to revolutionize the clinical treatment specific to cognitive deficits in SVHD and other types of congenital heart defects. In addition, the clinical implications are considerable as improved working memory skill has the potential to increase academic achievement, improve self-care, reduce mortality and morbidity, and increase quality of life in this high risk, growing population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adolescents with SVHD
All adolescents will receive the intervention Cogmed. This is an in home, computer based, cognitive intervention to improve working memory, supervised by trained coaches, \[25 sessions, each 30-45 minutes, 5 days a week / 5 week duration\].
Cognitive Computer Based Intervention
25 sessions \[each 30-45 minutes, 5 days a week / for 5 weeks\], supervised by trained coaches
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Computer Based Intervention
25 sessions \[each 30-45 minutes, 5 days a week / for 5 weeks\], supervised by trained coaches
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have SVHD
* undergone Fontan completion
* understands English
* able to read computer screen
* have phone access
* MoCA score of 25 to 10
Exclusion Criteria
* claustrophobia
* presence of loose metal
* prior head injury or stroke
* clinical diagnosis of depression
* previous cardiac arrest and ECMO use
* currently listed for heart transplant
* known genetic syndrome
* severe developmental delay
* born less than 35 weeks gestation
14 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nancy Pike, PhD, RN
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy Pike, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLA 300 Medical Plaza
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
92418
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.